Cisatracurium products: ambient stability during COVID-19

This page gives ambient stability information for Cisatracurium products during COVID-19.  Information here should be used in conjunction with our general advice.

Cisatracurium besilate 20mg/10ml solution for injection ampoules

  • Cisatracurium besilate 20mg/10ml solution for injection ampoules (Consilient Health Ltd)
  • Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharmaceuticals Ltd)
  • Cisatracurium besilate 20mg/10ml solution for injection ampoules (Mylan)
  • Nimbex 20mg/10ml solution for injection ampoules (Aspen Pharma Trading Ltd)

Can be stored at temperatures of up to 25°C for up to 30 days

Cisatracurium besilate 20mg/10ml solution for injection vials

  • Cisatracurium besilate 20mg/10ml solution for injection vials (Accord Healthcare Ltd)

Can be stored at temperatures of up to 25°C for up to 30 days

Cisatracurium besilate 150mg/30ml solution for injection vials

  • Cisatracurium besilate 150mg/30ml solution for injection vials (Accord Healthcare Ltd)
  • Cisatracurium besilate 150mg/30ml solution for injection vials (Mylan)
  • Nimbex Forte 150mg/30ml solution for injection vials (Aspen Pharma Trading Ltd)

Can be stored at temperatures of up to 25°C for up to 30 days

This page has been put together rapidly to help colleagues during the COVID-19 pandemic; if you spot anything that’s wrong or needs improving report a concern.